Insulet Corporation has received its long anticipated FDA clearance for its Omnipod 5 App for iPhone, becoming the first company to offer a tubeless automated insulin delivery system with complete control via compatible Android and iOS smartphones.
This approval enhances the Omnipod 5's position in phone-controlled AID systems, with the iPhone app offering the same features as its Android counterpart. The app includes a custom foods feature, allowing users to save carbohydrate data for frequently consumed items. It will integrate with the Dexcom G6 Continuous Glucose Monitoring System initially, with a full market release in 2024, and is available at no cost to Omnipod 5 System users. This development provides greater convenience for individuals managing type 1 diabetes.
DISCLAIMERS:
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.
danatech, powered by ADCES, helps the whole care team choose, start, use and support diabetes technology with confidence.